Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission

IntroductionClinical remission (CliR) achievement has been recognized as a new potential outcome in severe asthma. Nevertheless, we still lack a detailed profile of what features could better identify patients undergoing clinical remission. In this study, we aim to address this issue, tracing a poss...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Giovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, Aikaterini Detoraki, Alessandro Vatrella, Cecilia Calabrese, Corrado Pelaia, Francesca Montagnolo, Giulia Scioscia, Giuseppe Valenti, Maria D’Amato, Maria Filomena Caiaffa, Massimo Triggiani, Nicola Scichilone, Claudia Crimi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-01-01
Edice:	Frontiers in Immunology
Témata:	severe asthma anti-IL5 anti-IL5 receptor clinical remission biologics FEV1
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1343362/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!